It is now widely accepted that the cGAS-STING signaling cascade may rely primarily on synthetic interferons (IFNs) to exert anti-tumor effects, but recent studies have found that it also has significant regulatory effects on non-immune pathways and influences tumor progression. The gene discussed is CGAS; the disease is neoplasm.